HOXA2 and glioma: Abnormal DNA methylation of HOXA2 promoter regions causes dysregulation of gene expression, therefore influencing the invasion, prognosis, and clinical characteristics of colorectal cancer, glioma, and nasopharyngeal carcinoma (Li et al., 2013, 2019a; Liu et al., 2020).